Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.539NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-20541.9US
C.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.35NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.210NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.210NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
A.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.28NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.567NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.567NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
C.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.23NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
C.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.2.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.541NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.541NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.36.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.24NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18513.9US
B.1.1.25NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.189NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.189NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.563NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.563NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23275.1US
B.1.36.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.34NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.5.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.5.3 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BB.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.86 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.86 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.4.7 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.7 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.4.12 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.12 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.7.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.7.2 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.1.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.390NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.390NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
N.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.319NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.319NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BG.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.177.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.54NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.164NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used